Functional foods and dietary supplements: Products at the interface between pharma and nutrition
- 27 July 2011
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 668, S2-S9
- https://doi.org/10.1016/j.ejphar.2011.07.008
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr−/− micePharmacological Research, 2011
- Evaluation of Benefit-RiskPharmacoEconomics, 2010
- Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical ObservationsThe AAPS Journal, 2009
- Functional foods: the case for closer evaluationBMJ, 2007
- Molecular Genetics of Experimental Hypertension and the Metabolic SyndromeHypertension, 2007
- Advertising Campaigns of Sterol-Enriched Food. An Often Neglected Cause of Reduced Compliance to Lipid Lowering Drug TherapyCardiovascular Drugs and Therapy, 2007
- Drug-Drug and Food-Drug Pharmacokinetic Interactions with New Insulinotropic Agents Repaglinide and NateglinideClinical Pharmacokinetics, 2007
- Phytosterols and vascular diseaseAtherosclerosis, 2006
- Antacids RevisitedDrugs, 1999
- Decreased bioavailability of digoxin due to hypocholesterolemic interventions.Cell Metabolism, 1978